341 related articles for article (PubMed ID: 17994017)
1. PU.1 is a major downstream target of AML1 (RUNX1) in adult mouse hematopoiesis.
Huang G; Zhang P; Hirai H; Elf S; Yan X; Chen Z; Koschmieder S; Okuno Y; Dayaram T; Growney JD; Shivdasani RA; Gilliland DG; Speck NA; Nimer SD; Tenen DG
Nat Genet; 2008 Jan; 40(1):51-60. PubMed ID: 17994017
[TBL] [Abstract][Full Text] [Related]
2. Subnuclear targeting of Runx1 is required for synergistic activation of the myeloid specific M-CSF receptor promoter by PU.1.
Li X; Vradii D; Gutierrez S; Lian JB; van Wijnen AJ; Stein JL; Stein GS; Javed A
J Cell Biochem; 2005 Nov; 96(4):795-809. PubMed ID: 16149049
[TBL] [Abstract][Full Text] [Related]
3. Inability of RUNX1/AML1 to breach AML1-ETO block of embryonic stem cell definitive hematopoiesis.
Peterson LF; Lo MC; Okumura AJ; Zhang DE
Blood Cells Mol Dis; 2007; 39(3):321-8. PubMed ID: 17692541
[TBL] [Abstract][Full Text] [Related]
4. Lymphoid cell growth and transformation are suppressed by a key regulatory element of the gene encoding PU.1.
Rosenbauer F; Owens BM; Yu L; Tumang JR; Steidl U; Kutok JL; Clayton LK; Wagner K; Scheller M; Iwasaki H; Liu C; Hackanson B; Akashi K; Leutz A; Rothstein TL; Plass C; Tenen DG
Nat Genet; 2006 Jan; 38(1):27-37. PubMed ID: 16311598
[TBL] [Abstract][Full Text] [Related]
5. Roles of HIPK1 and HIPK2 in AML1- and p300-dependent transcription, hematopoiesis and blood vessel formation.
Aikawa Y; Nguyen LA; Isono K; Takakura N; Tagata Y; Schmitz ML; Koseki H; Kitabayashi I
EMBO J; 2006 Sep; 25(17):3955-65. PubMed ID: 16917507
[TBL] [Abstract][Full Text] [Related]
6. AML1(-/-) embryos do not express certain hematopoiesis-related gene transcripts including those of the PU.1 gene.
Okada H; Watanabe T; Niki M; Takano H; Chiba N; Yanai N; Tani K; Hibino H; Asano S; Mucenski ML; Ito Y; Noda T; Satake M
Oncogene; 1998 Nov; 17(18):2287-93. PubMed ID: 9811459
[TBL] [Abstract][Full Text] [Related]
7. PU.1: a crucial and versatile player in hematopoiesis and leukemia.
Kastner P; Chan S
Int J Biochem Cell Biol; 2008; 40(1):22-7. PubMed ID: 17374502
[TBL] [Abstract][Full Text] [Related]
8. The Pu.1 locus is differentially regulated at the level of chromatin structure and noncoding transcription by alternate mechanisms at distinct developmental stages of hematopoiesis.
Hoogenkamp M; Krysinska H; Ingram R; Huang G; Barlow R; Clarke D; Ebralidze A; Zhang P; Tagoh H; Cockerill PN; Tenen DG; Bonifer C
Mol Cell Biol; 2007 Nov; 27(21):7425-38. PubMed ID: 17785440
[TBL] [Abstract][Full Text] [Related]
9. Core binding factor genes and human leukemia.
Hart SM; Foroni L
Haematologica; 2002 Dec; 87(12):1307-23. PubMed ID: 12495904
[TBL] [Abstract][Full Text] [Related]
10. Role of PU.1 in hematopoiesis.
Fisher RC; Scott EW
Stem Cells; 1998; 16(1):25-37. PubMed ID: 9474745
[TBL] [Abstract][Full Text] [Related]
11. Cell-type-specific activation and repression of PU.1 by a complex of discrete, functionally specialized cis-regulatory elements.
Zarnegar MA; Chen J; Rothenberg EV
Mol Cell Biol; 2010 Oct; 30(20):4922-39. PubMed ID: 20696839
[TBL] [Abstract][Full Text] [Related]
12. PU.1 (Sfpi1), a pleiotropic regulator expressed from the first embryonic stages with a crucial function in germinal progenitors.
Olive V; Wagner N; Chan S; Kastner P; Vannetti C; Cuzin F; Rassoulzadegan M
Development; 2007 Nov; 134(21):3815-25. PubMed ID: 17913791
[TBL] [Abstract][Full Text] [Related]
13. Regulation of macrophage and neutrophil cell fates by the PU.1:C/EBPalpha ratio and granulocyte colony-stimulating factor.
Dahl R; Walsh JC; Lancki D; Laslo P; Iyer SR; Singh H; Simon MC
Nat Immunol; 2003 Oct; 4(10):1029-36. PubMed ID: 12958595
[TBL] [Abstract][Full Text] [Related]
14. PU.1 and hematopoiesis: lessons learned from gene targeting experiments.
Simon MC
Semin Immunol; 1998 Apr; 10(2):111-8. PubMed ID: 9618756
[TBL] [Abstract][Full Text] [Related]
15. Visualizing PU.1 activity during hematopoiesis.
Back J; Allman D; Chan S; Kastner P
Exp Hematol; 2005 Apr; 33(4):395-402. PubMed ID: 15781329
[TBL] [Abstract][Full Text] [Related]
16. PU.1 immortalizes hematopoietic progenitors in a GM-CSF-dependent manner.
Houston IB; Huang KJ; Jennings SR; DeKoter RP
Exp Hematol; 2007 Mar; 35(3):374-384. PubMed ID: 17309818
[TBL] [Abstract][Full Text] [Related]
17. Definition of regulatory network elements for T cell development by perturbation analysis with PU.1 and GATA-3.
Anderson MK; Hernandez-Hoyos G; Dionne CJ; Arias AM; Chen D; Rothenberg EV
Dev Biol; 2002 Jun; 246(1):103-21. PubMed ID: 12027437
[TBL] [Abstract][Full Text] [Related]
18. The ability of MLL to bind RUNX1 and methylate H3K4 at PU.1 regulatory regions is impaired by MDS/AML-associated RUNX1/AML1 mutations.
Huang G; Zhao X; Wang L; Elf S; Xu H; Zhao X; Sashida G; Zhang Y; Liu Y; Lee J; Menendez S; Yang Y; Yan X; Zhang P; Tenen DG; Osato M; Hsieh JJ; Nimer SD
Blood; 2011 Dec; 118(25):6544-52. PubMed ID: 22012064
[TBL] [Abstract][Full Text] [Related]
19. Transcriptional regulation of the human prostacyclin receptor gene is dependent on Sp1, PU.1 and Oct-1 in megakaryocytes and endothelial cells.
Turner EC; Kinsella BT
J Mol Biol; 2009 Feb; 386(3):579-97. PubMed ID: 19118563
[TBL] [Abstract][Full Text] [Related]
20. Developmentally regulated promoter-switch transcriptionally controls Runx1 function during embryonic hematopoiesis.
Pozner A; Lotem J; Xiao C; Goldenberg D; Brenner O; Negreanu V; Levanon D; Groner Y
BMC Dev Biol; 2007 Jul; 7():84. PubMed ID: 17626615
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]